ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.
Read More…
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Phone972-4959-0123
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$6.55 million
Profitability
Miscellaneous
Employees58
Next Earnings Date11/14/2019 (Estimated)
OptionableNot Optionable
Rewalk Robotics (NASDAQ:RWLK) Frequently Asked Questions
What is Rewalk Robotics' stock symbol?
Rewalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."
How were Rewalk Robotics' earnings last quarter?
Rewalk Robotics Ltd (NASDAQ:RWLK) posted its quarterly earnings data on Thursday, August, 8th. The medical device company reported ($0.88) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.49) by $0.39. The medical device company had revenue of $0.88 million for the quarter, compared to analyst estimates of $2.48 million. Rewalk Robotics had a negative return on equity of 452.23% and a negative net margin of 320.80%. View Rewalk Robotics' Earnings History.
When is Rewalk Robotics' next earnings date?
What price target have analysts set for RWLK?
1 Wall Street analysts have issued 12 month target prices for Rewalk Robotics' stock. Their forecasts range from $9.00 to $9.00. On average, they expect Rewalk Robotics' stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 183.9% from the stock's current price. View Analyst Price Targets for Rewalk Robotics.
What is the consensus analysts' recommendation for Rewalk Robotics?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rewalk Robotics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rewalk Robotics.
Has Rewalk Robotics been receiving favorable news coverage?
Media coverage about RWLK stock has trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Rewalk Robotics earned a media sentiment score of -1.5 on InfoTrie's scale. They also gave media coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Rewalk Robotics.
Are investors shorting Rewalk Robotics?
Rewalk Robotics saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 374,500 shares, an increase of 6.6% from the August 30th total of 351,400 shares. Based on an average trading volume of 153,700 shares, the days-to-cover ratio is currently 2.4 days. Currently, 5.7% of the shares of the company are sold short. View Rewalk Robotics' Current Options Chain.
Who are some of Rewalk Robotics' key competitors?
What other stocks do shareholders of Rewalk Robotics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Rewalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners, L.P (CLMT), Two Harbors Investment (TWO), Novocure (NVCR), Blackrock Capital Investment (BKCC), Viper Energy Partners (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG) and Park Sterling (PSTB).
Who are Rewalk Robotics' key executives?
Rewalk Robotics' management team includes the folowing people:
- Mr. Lawrence J. Jasinski, CEO & Director (Age 62)
- Mr. Ori Gon, Chief Financial Officer (Age 38)
- Ms. Miri Pariente, VP of QA & Operations (Age 42)
- Mr. Loren Wass, VP of Sales & Reimbursement
- Mr. Andy Dolan, VP of Marketing
How do I buy shares of Rewalk Robotics?
Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Rewalk Robotics' stock price today?
One share of RWLK stock can currently be purchased for approximately $3.17.
How big of a company is Rewalk Robotics?
Rewalk Robotics has a market capitalization of $23.11 million and generates $6.55 million in revenue each year. The medical device company earns $-21,670,000.00 in net income (profit) each year or ($14.75) on an earnings per share basis. Rewalk Robotics employs 58 workers across the globe.View Additional Information About Rewalk Robotics.
What is Rewalk Robotics' official website?
How can I contact Rewalk Robotics?
Rewalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123 or via email at [email protected]
MarketBeat Community Rating for Rewalk Robotics (NASDAQ RWLK)
MarketBeat's community ratings are surveys of what our community members think about Rewalk Robotics and other stocks. Vote "Outperform" if you believe RWLK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RWLK will underperform the S&P 500 over the long term. You may vote once every thirty days.
